The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Open accessAbstract
Cardiovascular disease is a leading cause of morbidity and mortality in individuals with type 2 diabetes mellitus. These high-risk patients benefit from aggressive risk factor management, with blood pressure and low-density lipoprotein-cholesterol treatment, glycemic control, kidney protection, and lifestyle intervention. There are several recommendation and guideline documents across cardiology, endocrinology, nephrology, and general medicine professional societies from the United States and Europe with recommendations for cardiovascular risk reduction in patients with type 2 diabetes mellitus. Although there are some noteworthy differences, particularly in risk stratification, low-density lipoprotein-cholesterol and blood pressure treatment targets, and the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, overall there is considerable alignment across recommendations from different professional societies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, individuals with diabetes and prediabetes often have barriers to exercise due to being frail or functionally compromised;9 therefore, tolerating long-lasting moderate-to-vigorous intensity PA (MVPA) as recommended (at least 150 min/week) is difficult for them.8”
From Accelerometer-measured physical activity, sedentary behavior, and incidence of macrovascular and microvascular events in individuals with type 2 diabetes mellitus and prediabetes (2025) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Based on evidence from large cardiovascular outcomes trials, the latest professional society guidelines continue to recommend sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for patients with type 2 diabetes (T2D) and established cardiovascular disease (CVD).1,2”
In the citing paper
“Multiple professional societies issue recommendations for care of people with diabetes, CKD, or both, 44 and the existence of multiple guidelines can create the appearance of inconsistency.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Dapagliflozin in Patients with Chronic Kidney Disease
Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.002 · Cited by 1,751
Cited by
Sorted by citations
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.013 · Cited by 274
Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m22-2904 · Cited by 248
The emergence of obesity in type 1 diabetes
Kueh, M. T. W., Chew, N., Al‐Ozairi, E., & le Roux, C. W. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01429-8 · Cited by 135
Bempedoic Acid: for Whom and When
Ruscica, M., Sirtori, C. R., Carugo, S., Banach, M., & Corsini, A. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01054-2 · Cited by 95
Zhang, S., Qi, Z., Wang, Y., Song, D., & Zhu, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1203666 · Cited by 87
Luo, J., Feldman, R., Callaway Kim, K., Rothenberger, S., Korytkowski, M., Hernandez, I., & Gellad, W. F. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.17886 · Cited by 75
Statin initiation and risk of incident kidney disease in patients with diabetes
Zhou, S., Su, L., Xu, R., Li, Y., Chen, R., Cao, Y., Gao, P., Zhang, X., Luo, F., Gao, Q., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230093 · Cited by 52
Scisciola, L., Taktaz, F., Fontanella, R. A., Pesapane, A., Surina, Cataldo, V., Ghosh, P., Franzese, M., Puocci, A., Paolisso, P., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01754-2 · Cited by 50
Guan, H., Tian, J., Wang, Y., Niu, P., Zhang, Y., Zhang, Y., Fang, X., Miao, R., Yin, R., & Tong, X. (2024) · European journal of medical research · doi:10.1186/s40001-024-01739-1 · Cited by 55
Fazio, S., Mercurio, V., Tibullo, L., Fazio, V., & Affuso, F. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1380506 · Cited by 46
Deng, M., Wen, Y., Yan, J., Fan, Y., Wang, Z., Zhang, R., Ren, L., Ba, Y., Wang, H., Lü, Q., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-03129-6 · Cited by 40
Yang, T., & Zhang, D. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101884 · Cited by 30
Kunutsor, S. K., & Seidu, S. (2025) · Drugs · doi:10.1007/s40265-025-02263-0 · Cited by 36
Oh, S., Lee, J., Hong, Y. S., & Kim, K. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad046 · Cited by 28
Early combination therapy with SGLT2i and GLP ‐1 RA or dual GIP / GLP ‐1 RA in type 2 diabetes
Vale, C., Lourenço, I. M., Jordan, G., Golovaty, I., Torres, H., Moin, T., Buysschaert, M., Neves, J. S., & Bergman, M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16077 · Cited by 29
Savytska, M., Kyriienko, D., Komisarenko, I., Kovalchuk, O. I., Falalyeyeva, T. M., & Kobyliak, N. M. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01474-6 · Cited by 28
Liang, Y. Y., He, Y., Huang, P., Feng, H., Li, H., Ai, S., Du, J., Xue, H., Liu, Y., Zhang, J., et al. (2025) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2024.100973 · Cited by 25
Affuso, F., Micillo, F., & Fazio, S. (2024) · Biomedicines · doi:10.3390/biomedicines12081888 · Cited by 25
Firkins, S. A., Chittajallu, V., Flora, B., Yoo, H., & Simons-Linares, C. R. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07181-w · Cited by 23
Sawami, K., Tanaka, A., & Node, K. (2023) · Hypertension Research · doi:10.1038/s41440-023-01324-9 · Cited by 19
Tang, H., Zhang, B., Lu, Y., Donahoo, W. T., Ospina, N. S., Kotecha, P., Lu, Y., Tong, J., Smith, S. M., Rosenberg, E. I., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16147 · Cited by 18
Quesada-Caballero, M., Carmona-García, A., Chami-Peña, S., Caballero-Mateos, A. M., Fernández-Martín, O., la Fuente, G. A. C., & Romero‐Béjar, J. L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196160 · Cited by 17
Ferrara, F., Zovi, A., Langella, R., Cavallaro, F., Nava, E., Trama, U., & Vitiello, A. (2023) · International Journal of Healthcare Management · doi:10.1080/20479700.2023.2210393 · Cited by 15
Wander, G. S., Panda, J. K., Pal, J., Mathur, G., Sahay, R. K., TIWASKAR, M. H., Chatterjee, N., Chakrabarty, S., Singh, D. P., Murthy, L. S., et al. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0620 · Cited by 16
Liang, J., Li, Q., Fu, Z., Liu, X., Shen, P., Sun, Y., Zhang, J., Lu, P., Lin, H., Tang, X., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad198 · Cited by 15
Cavalli, N. P., de Mello, M. B., Righi, N. C., Schuch, F. B., Signori, L. U., & da Silva, A. M. V. (2024) · Journal of Sports Sciences · doi:10.1080/02640414.2024.2330232 · Cited by 17
Kindlovits, R., Sousa, A., Viana, J. L., Milheiro, J., Oliveira, B. M. P. M., Marques, F., Santos, A., & Teixeira, V. H. (2024) · Nutrients · doi:10.3390/nu16111624 · Cited by 14
Lei, D., Sun, Y., Liu, J., & Chi, J. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3781 · Cited by 12
Alòs, F., Colomer, M. À., Bort-Roig, J., Martin-Cantera, C., Minaya, A., Saigí, I., Sitjar-Suñer, M., & Puig-Ribera, A. (2025) · Primary Care Diabetes · doi:10.1016/j.pcd.2025.05.010 · Cited by 15
Epigenetic biomarkers predict macrovascular events in individuals with type 2 diabetes
García-Calzón, S., Maguolo, A., Eichelmann, F., Edsfeldt, A., Perfilyev, A., Maziarz, M., Lindström, A., Sun, J., Brīvība, M., Schulze, M. B., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102290 · Cited by 11
Yang, C. X., Zhu, C., Guo, Y., Wu, N., Dong, Q., Xu, R., Yongjian, W., Qian, J., & Li, J. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0410 · Cited by 8
Ma, J., Wu, P., Ma, S., Ma, X., Jin, P., & Jia, S. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1386318 · Cited by 11
BMP2 enhance the osteogenic effect of BMSCs-derived exosomes in skull defect of diabetic rats
He, Y., Wang, Y., Yu, S., Wang, L., Dou, Y., Ma, R., Cao, S., Song, W., & Ma, P. (2024) · Materials & Design · doi:10.1016/j.matdes.2024.113517 · Cited by 8
Nelson, A. J., Kaltenbach, L. A., McGuire, D. K., Levya, M., Al‐Khalidi, H. R., Webb, L. E., Lópes, R. D., Pop‐Busui, R., Cavender, M. A., Aroda, V. R., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.12.006 · Cited by 8
Self-citationCecchini, A. L., Biscetti, F., Manzato, M., Sasso, L. L., Rando, M. M., Nicolazzi, M. A., Rossini, E., Eraso, L. H., DiMuzio, P. J., Massetti, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216099 · Cited by 11
Tan, J., Yang, Y., Wang, J., Wang, Y., Lv, T., Shu, Y., Xu, W., & Chong, L. (2024) · BioScience Trends · doi:10.5582/bst.2024.01006 · Cited by 8
Luca, S. A., Bungau, R. M., Lazăr, S., Potre, O., & Timar, B. (2024) · Medicina · doi:10.3390/medicina60020334 · Cited by 9
Molinsky, R. L., Shah, A. M., yuzefpolskaya, M., Yu, B., Misialek, J. R., Bohn, B., Vock, D. M., MacLehose, R. F., Borlaug, B. A., Colombo, P. C., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.123.033877 · Cited by 7
Meng, P.-N., Nong, J., Xu, Y., You, W., Xu, T., Wu, X., Wu, Z., Tao, B., Guo, Y.-J., Yin, D., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-32638-w · Cited by 7
Zhang, S., Chen, S., He, K., Liu, J., Su, X. B., Li, W., Ma, J., Chen, C., Ouyang, R., Mu, Y., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300332 · Cited by 7
Huang, X., Jiang, D., Feng, X., & Fang, Z.-M. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176698 · Cited by 6
Alhomoud, I. S., & Alamer, K. A. (2025) · Pharmaceuticals · doi:10.3390/ph19010009 · Cited by 6
Zhu, K., Geng, T., Qiu, Z., Li, R., Lin, L., Li, R., Chen, X., Pan, A., Manson, J. E., & Liu, G. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae050 · Cited by 7
Oniki, K., Shigaki, T., Kajiwara‐Morita, A., Shigetome, K., Yoshida, A., Jinnouchi, H., & Saruwatari, J. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103225 · Cited by 5
Chwal, B. C., dos Reis, R. C. P., Schmidt, M. I., Ribeiro, A. L. P., Barreto, S. M., Griep, R. H., Lotufo, P. A., & Duncan, B. B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247667 · Cited by 6
Xiang, X., Chen, G., Ma, Y., & Wang, H. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102840 · Cited by 5
Song, K., Liang, D., Xiao, D., Kang, A., & Ren, Y. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13323 · Cited by 5
Kelsey, M. D., Ford, C. B., Oakes, M. M., Soneji, S. S., Bosworth, H. B., & Pagidipati, N. J. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.47102 · Cited by 5
Self-citationKindlovits, R., Sousa, A., Viana, J. L., Milheiro, J., Marques, F., & Teixeira, V. H. (2023) · Nutrition and Health · doi:10.1177/02601060231190663 · Cited by 4
Zhang, J., Guo, Y., Wei, C., Yu, Y., Shan, H., Wu, B., & Wu, F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1363501 · Cited by 4
Lhoëst, M. T. L. C., Martínez, A., Garcı́a, E., Dandurand, J., Polishchuk, A., Benitez‐Amaro, A., Cenarro, A., Civeira, F., Bernabé, A., Viladés, D., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100703 · Cited by 4
Khattab, M. A., Khalil, S. H. A., Bassyouni, A., Fawzy, F., Elgayar, A. H., Elebrashy, I., Elhadidy, K. E., Abdallah, K., El-Hefnawy, M. H., Halawa, M. R., et al. (2025) · BMC Family Practice · doi:10.1186/s12875-025-03091-7 · Cited by 4
Pokrovskaya, E. V., Shestakova, E. A., & Shestakova, M. V. (2023) · Diabetes Mellitus · doi:10.14341/dm13088 · Cited by 3
Trillini, M., Jenssen, T. G., Martin, W. P., & Morales, E. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaf008 · Cited by 3
Rossing, P. R., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2481-2004 · Cited by 3
Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure
Darwish, D., Kumar, P., Urs, K., & Dave, S. (2025) · Cells · doi:10.3390/cells14120919 · Cited by 5
Prevalence and patterns of catastrophic spending for antidiabetic medication in 2020
Devine, J. W., Lim, D., Lugo, A. M., & Farley, J. F. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.10.1158 · Cited by 3
Greco, S., Salatiello, A., Motoli, F. D., Giovine, A., Veronese, M., Cupido, M. G., Pedarzani, E., Valpiani, G., & Passaro, A. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02245-8 · Cited by 3
Nishida, A., Ogawa, O., & TAKIZAWA, H. (2022) · Cureus · doi:10.7759/cureus.29974 · Cited by 2
So, J., Chung, K., Seo, J., Kim, B., Chun, H., Han, S. N., & Chung, I.-M. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1221916 · Cited by 2
Mirghani, H. O. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v16.i1.98804 · Cited by 2
Fojas, E. G., Haidery, A., Naseeb, S., & Naemi, R. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109003 · Cited by 3
van der Heide, F. C. T., Steens, I. L. M., Singh‐Manoux, A., Sabia, S., Zhou, T. L., Köhler, S., Schram, M. T., Kallen, C., Berendschot, T. T. J. M., Webers, C. A. B., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02888-1 · Cited by 2
Rawat, S., Yadav, R., Goyal, S., & Nagpal, J. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102880 · Cited by 2
Buenaventura, D. C., Ramos, A. F. G., Valencia, C. M. B., Aguilar-Londoño, C., Coronel-Restrepo, N., Monsalve, C., Cuesta, D., & Rincón, A. R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1372992 · Cited by 1
Kim, H., Lee, S. W., Lim, Y., Han, N., Kang, S. H., Byun, Y., & Kim, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333604 · Cited by 1
Amelia, R., Pranata, C., Dewi, T. K., & Nasution, A. M. (2026) · Current Diabetes Reviews · doi:10.2174/0115733998379857251113060856 · Cited by 1
Fazio, S., & Carlomagno, G. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1719492 · Cited by 3
Li, Z., Huang, J., Zhou, S., Luan, Y., Xie, H., Chen, Z., Xu, J., & Qian, J. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/8893769 · Cited by 1
Type 2 Diabetes Mellitus: Molecular Pathogenesis and Therapeutic Interventions
Fei, S., Xiong, X., Zhang, L., Zhang, J., Chan, L. W. C., Jiang, H., Xiong, Q., Changtao, H., Chen, J., & Yang, S. (2026) · MedComm · doi:10.1002/mco2.70895 · Cited by 1
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?
Malkani, N. P., & Aroda, V. R. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000787 · Cited by 1
Li, Y., Yan, M., Cai, Q., Tse, L. A., Liu, Z., Lang, X., Wang, B., Ma, Q., Li, M., Qiu, Q., et al. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04148 · Cited by 1
Gao, X., Jiang, M., Huang, N., Guo, X., Baccarelli, A., & Huang, T. (2022) · medRxiv · doi:10.1101/2022.09.15.22280006
Managing Stable Coronary Artery Disease in Diabetes
Koulouridis, I., & Johnstone, M. T. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_23
PERIOPERATIVE PREPARATION OF PATIENTS RECEIVING GLP-1 RECEPTOR AGONISTS
Daniyalova, N. D. (2023) · Современные проблемы науки и образования · doi:10.17513/spno.33167
Raven, L. M. (2024) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2024.03.007
Cardiovascular Disease Risk and Risk Reduction Strategies in Diabetes Mellitus
Wilson, D. P., Hamilton, L., & Maki, K. C. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_14
Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7568-2_8
Andersen, J. W., Høgh, A. L., Lindholt, J. S., Søgaard, R., Støvring, H., Yderstræde, K. B., Sandbæk, A., & Dahl, M. (2025) · Clinical Epidemiology · doi:10.2147/clep.s487825
Builes-Montaño, C. E., Suarez-Rodriguez, A. F., & Carreño, J. (2025) · F1000Research · doi:10.12688/f1000research.159628.1
(2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21835-4.00116-5
Herbal medicine for experimental type 2 diabetes and atherosclerosis
Białoszycka, Ż., Biloshytska, A., Białoszycka, M. M., Pachevska, A. V., & Vasyliev, M. (2025) · Quality in Sport · doi:10.12775/qs.2025.41.60382
Zhang, X., Jiang, C., Ye, Z., Zhang, Y., & Zhang, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1547078
Li, Y., Li, L., & He, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1557185
Accoceberry, L., Alam, U., Fauchier, G., Lochon, L., Bisson, A., Ducluzeau, P., Lip, G. Y. H., & Fauchier, L. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101690
Amorim, J. L., Benseñor, I. M., Alencar, A. P., Pereira, A. C., Goulart, A. C., Lotufo, P. A., & Santos, I. S. (2025) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2025e14986
The GLP-1 Receptor Agonist Revolution
Nicholls, S. J., & Nelson, A. J. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.083
Self-citationDeng, M., Wen, Y., Yan, J., Fan, Y., Wang, Z., Zhang, R., Ren, L., Ba, Y., Wang, H., Lu, Q., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24580347
Okoro, C., Zhou, T. L., Kallen, C., Koster, A., Sutedja, N. A., Berendschot, T. T. J. M., de Galan, B. E., Eussen, S. J. P. M., Schram, M. T., & Kroon, A. A. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113212
Wang, J., Yu, L., Yin, J., Yin, Y., Qi, X., & Wu, Y. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2642478
Fazio, S., & Affuso, F. (2026) · Chronic Diseases and Translational Medicine · doi:10.1002/cdt3.70050
Cardiovascular risk factors in adults with type 2 diabetes mellitus: Retrospective study
Ríos, E. D. S. G., Yupari-Azabache, I. L., Otiniano, N. M., & Gómez-Goicochea, N. I. (2026) · F1000Research · doi:10.12688/f1000research.181792.1
Islam, M. M., & Okere, A. N. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113346
Role of Macrophage Efferocytosis in Cardiovascular Homeostasis and Disease
Lin, H., Zhu, X., Sun, Y., Yang, Y., Fan, A., Yang, K., Gao, Z., Ma, C., Fan, G., & Li, L. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl49006
young-hye, C., Choi, J. I., & Lee, S. Y. (2026) · World Journal of Diabetes · doi:10.4239/wjd.120422
Mohanty, S. S., Selvammathy, R. R., Ahad, H. A., & Kumar, E. S. (2026) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_1384_25
Rayappan, M. N. F., William, N., Kuppuswami, G., Irudayam, J., Ravi, R., & Mariyappan, R. (2026) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2026.034.2.15
Niu, X., Zhang, Y., Liu, Y., Zhu, Y. Z., Fang, B., Hu, C., Xu, X., Wang, R. T., Sang, Y., Zhang, Q., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1803814
Diet and nutrition modifications for cardiovascular health
Liu, T., & Jia, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34186-1.00017-7
Metadata
- Authors
- Kelsey, M. D., Nelson, A. J., Green, J. B., Granger, C. B., Peterson, E. D., McGuire, D. K., & Pagidipati, N. J.
- Affiliations
- Duke University (US)
- Duke Clinical Research Institute (US)
- Duke Medical Center (US)
- Parkland Health & Hospital System (US)
- Corresponding author
- Kelsey, Michelle D.
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 79
- Issue
- 18
- Pages
- 1849-1857
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W4225270796
- Cited by
- 106
- References
- 48
- Citations by year
- 2026: 21 · 2025: 22 · 2024: 32 · 2023: 25 · 2022: 6
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- type 2 diabetes, cardiovascular risk reduction, cardiovascular disease, glycemic control, renal protection, lifestyle intervention, SGLT2 inhibitors, GLP-1 receptor agonists, risk stratification, professional society recommendations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
